| 3/20/2015 | PP | Oxigene plans to conduct $10 million registered offering of its units
|
| 5/23/2014 | PP | Oxigene raises $16 million in at-the-market direct offering of stock
|
| 2/12/2014 | PP | Oxigene prices $12 million public offering of units at $2.05 per unit
|
| 9/19/2013 | PP | Oxigene eyes $5.8 million private placement of convertible preferreds
|
| 8/29/2013 | PP | Oxigene reports it now plans to sell common shares in public offering
|
| 8/8/2013 | PP | Oxigene will price $20 million public offering of common-share units
|
| 4/11/2013 | PP | Oxigene plans $5 million private placement of convertible preferreds
|
| 9/5/2012 | PP | Oxigene plans to conduct $2.94 million at-the-market sale of shares
|
| 6/14/2012 | PP | Oxigene to raise $10 million via at-market issuance sales agreement
|
| 11/28/2011 | PP | Oxigene secures $20 million through common stock purchase agreement
|
| 10/14/2011 | PP | Oxigene terminates its $40 million committed equity financing facility
|
| 7/8/2011 | PP | Oxigene to conduct a $3.1 million at-market issuance sales agreement
|
| 6/29/2011 | PP | Oxigene raises $15.18 million via at-market issuance sales agreement
|
| 3/11/2010 | PP | New Issue: Oxigene to pocket $7.5 million via private placement of common shares
|
| 3/11/2010 | PP | Market Commentary: Candax seeks C$13 million; Image Metrics pockets $8 million; Oxigene plans stock, warrant sale
|
| 7/15/2009 | PP | New Issue: Oxigene orchestrates $10 million direct offering of common share units
|
| 7/15/2009 | PP | Market Commentary: GTO aims for C$100 million; Oxigene plans direct offering; Manas wraps A$4 million equity deal
|
| 10/2/2008 | PP | Market Commentary: Cosan plans $180 million private placement of shares; Oxigene completes $2.48 million PIPE sale
|
| 10/1/2008 | PP | New Issue: Oxigene secures $2.48 million from private placement of shares
|
| 2/22/2008 | PP | Market Commentary: Lumera obtains $25 million equity line; Elandia sells $40 million preferreds
|
| 2/21/2008 | PP | New Issue: Oxigene releases further details on $40 million committed equity financing facility
|
| 2/21/2008 | PP | Market Commentary: Romarco opts for non-brokered sale; Sterling plans C$35 million deal; Nemi Northern prices notes
|
| 2/20/2008 | PP | New Issue: Oxigene arranges $40 million committed equity financing facility
|
| 2/20/2008 | PP | Market Commentary: HSW snags $18.4 million investment; Mountain Lake plans sale; Oxigene gets $40 million financing deal
|
| 3/8/2005 | PP | Market Commentary: Private placements stall on lower stocks; Vistula closes $8.4 million offering
|
| 3/7/2005 | PP | Market Commentary: Canadian private placement issuance powered by oil; Producers prices C$80 million deal
|
| 3/4/2005 | PP | New Issue: Oxigene closes direct placement of stock for $15.01 million
|
| 3/4/2005 | PP | Market Commentary: Private placement volume gets boost from stocks; Oxigene closes $15 million deal
|
